WeightWatchers (WW): Buy, Sell, or Hold Post Q1 Earnings?
Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community
Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program
WW International's Weight Watchers Med+ Will Support Medicare Members Seeking Access To GLP-1s Under The Medicare GLP-1 Bridge Program
Weight Watchers to Support the American Heart Association’s Healthy Living BEYOND Weight Study
WW International To Encourage Members To Enroll And Participate In The American Heart Association's Healthy Living BEYOND Weight Study
Consumer Discretionary - Specialized Consumer Services Stocks Q1 Teardown: WeightWatchers (NASDAQ:WW) Vs The Rest
Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK
WW International And CheqUp Expand Partnership To Deliver Behavioural And Clinical Support For People On Weight Management Journey In UK
WW International: New Initiatives Not Enough
WW (WW) Q4 2025 Earnings Call Transcript
WW International 13D Filing Shows Galloway Capital Partners Reports 8.42% Stake In Co As Of May 13, 2026
WW International, Inc. 2026 Q1 - Results - Earnings Call Presentation
WW International, Inc. (WW) Q1 2026 Earnings Call Transcript
WW International Q1 Revenue Beats, But Subscriber Decline, EBITDA Loss Sink Shares
WW International Q1 EPS $(5.20) Misses $(2.51) Estimate, Sales $168.261M Beat $158.550M Estimate
WW International Affirms FY2026 Sales Guidance of $620.000M-$635.000M vs $633.445M Est
WW International shares are trading higher after the company announced that it plans to use up to $40 million cash to prepay and pay down principal on its outstanding term loan.
Reported Earlier: WW International Plans Up to $40M Term Loan Paydown Through Cash Sweep And Discounted Debt Repurchase Initiative
WW International shares are trading higher after the company announced it has started offering access to Eli Lilly's weight loss drug, Foundayo, under its Med+ platform and related medical groups.
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.